Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Combining Ibrutinib with immune checkpoint blockade to induce therapeutic antitumor immune response in solid tumors Sagiv-Barfi, I., Kohrt, H., Czerwinski, D., Ng, P., Chang, B., Levy, R. AMER ASSOC CANCER RESEARCH. 2015
View details for DOI 10.1158/1538-7445.AM2015-251
View details for Web of Science ID 000371578500237